The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...
The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results